Pharmaceutical manufacturer for Sodium lactate

Pfanstiehl is globally recognized as a leader in manufacturing cGMP high-purity, low-endotoxin, low-metal injectable-grade excipients and biopharmaceutical components for various applications in bioprocessing, formulation, and specialty areas. Additionally, Pfanstiehl operates as a prominent contract development and manufacturing organization (CDMO), specializing in the isolation, purification, custom synthesis, and scale-up development of small molecule Active Pharmaceutical Ingredients (APIs) ranging from gram to multi-ton commercial quantities. While many ingredient manufacturers or resellers cater to various industries like food, cosmetics, agriculture, and nutritional supplements, providing only a limited range of “pharma-grade” ingredients, Pfanstiehl’s exclusive focus lies in Biopharma applications, demonstrating a dedicated commitment to this specific sector

ROQUETTE is dedicated to providing the finest from natural sources. It stands as a worldwide frontrunner in plant-derived components, an innovator in plant-derived proteins, and a top supplier of medical excipients. By working alongside its clients and associates, the organization tackles present and future societal obstacles by harnessing the capabilities of nature to present superior ingredients for the food, nutrition, and health sectors. These components satisfy distinct and vital requirements, promote healthier ways of living, and are essential elements of life-preserving medications.

Established in 1922 with the goal of supporting researchers, the Wako Group has been dedicated to advancing scientific development by providing laboratory chemicals. The organization values maintaining trusted relationships with researchers and customers, improving product quality and services, contributing to scientific and medical advancements, and upholding these commitments conscientiously. The Wako Way is a new philosophy based on these values, consisting of three key elements.

Locate additives provided by Corbion for utilization in pharmaceutical delivery systems (DDS). Additionally, obtain contact information and details regarding Corbion's regulatory submissions (DMFs), cGMP inspections, accreditations, etc.

The surrounding global environment is undergoing rapid change. In the realm of industry and economics, advancements in information technology, globalization, and liberalization are progressing swiftly. Additionally, as members of society, it is our solemn responsibility to safeguard the invaluable Earth's environment. Since 1918, SHOWA KAKO has been contributing a diverse range of chemical products to the chemical industry. These swift transformations compel us to adapt in a constructive and resolute manner. We acknowledge the impact of emerging scientific technology, which serves as the foundation for various technologies.

Taihei Shoji Co.Ltd originated as a subsidiary of Fujisawa Pharmaceutical Co.Ltd and was founded with a capital of 100,000yen. It merged with Nihon Nensei Chemical Industry Co.,Ltd. and commenced production of Activated Carbon at the Gifu Factory in response to increased demand for phosphate compounds. Subsequently, the Kasugai Factory was established. In 1957, the Gifu Factory was closed after relocation was completed.

Luoyang Longmen Pharmaceutical Co., Ltd formerly operated as Yanshi Lactate Limited Company, established in 1996. It focuses on the production of active pharmaceutical ingredients (APIs), such as pharmaceutical grade calcium lactate, calcium hydrogen phosphate, sodium lactate solution, and lactic acid. To meet customer demands for high-quality and large-quantity products, the company relocated its operations to Luoning Industrial Park, where a new building was reconstructed and completed in 2014. The new plant spans an area of 30000 square meters, with fixed assets amounting to ninety six million Yuan (RMB).